1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Opsoclonus-Myoclonus Syndrome: new trials by email Literature Review of Opsoclonus-Myoclonus Syndrome trials Research Report on Opsoclonus-Myoclonus Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) Dexamethasone acetate, dexamethasone and cyclophosphamide, dexamethasone and rituximab - Opsoclonus Myoclonus Syndrome, Neuroblastoma | Phase 3 | Completed | Institut Curie | 102 | 2013-04-18 | 2025-02-03 |
Neuroblastoma (1)
Central Nervous System Diseases (1) · Cranial Nerve Diseases (1) · Dyskinesias (1) · Eye Diseases (1) · Myoclonus (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neurodegenerative Diseases (1)
Cyclophosphamide (1) · Dexamethasone (1) · Rituximab (1) · dexamethasone acetate (1)
Institut Curie (1)
Austria (1) · France (1) · Italy (1) · Spain (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)